Umbilical stem cell treatment has been shown to be effective in treating many maladies and conditions, including degenerative and rheumatoid pain along with tendonitis, sports injuries, and ligament injuries. These conditions may be extremely painful, and they can severely inhibit one’s ability to perform daily tasks and enjoy a productive life. For years, these conditions were treated with injection therapy that included cortisone and steroid shots. But injection therapy at R3 Stem Cell utilizes umbilical cord stem cells that have proven to be more effective and less risky than these other types.
Umbilical Stem Cell Therapy Basics
The use of drugs such as steroids can reduce painful inflammation. That is the primary benefit for this type of treatment. Umbilical stem cell therapy offers a lot of benefits including decreasing inflammation and it’s not a steroid. Along with decreasing inflammation and pain in the joints of those with rheumatoid and degenerative arthritis, it also can replace damaged cells and make joints and tendons move more easily. The latter benefit is due to the fact that stem cell injections contain hyaluronic acid, which is the “motor oil” naturally found in our joints.
The Process
Stem cell therapy uses cells that are harvested from umbilical cord derived from a consenting mother who has given birth via a cesarean section. These stem cells, which are versatile due to their ability to differentiate in several ways, are injected into the affected joints or soft tissue.
The treatment is performed on an outpatient basis and takes about half an hour, is extremely low-risk and patient rejection is unusual due to the fact that these cells are not recognized by a patient’s immune system. They are immunologically privileged. Thus, when they are injected into the damaged site they are able to function uninhibited and in an active and positive manner, repairing the area.
Transformative Benefits of Umbilical Stem Cell Therapy
The positive results of umbilical stem cell therapy for degenerative and rheumatoid arthritis are numerous. First, unlike drug injection therapies, the results tend to be ongoing, with progressive improvement being common. The growth factor, which is an inherent aspect of umbilical stem cells, allows for the regeneration of tissue and cartilage. That means that degenerated tissue and cartilage are restored through this therapy. This type of therapy has been used hundreds of thousands of times with no ill effects.
Additionally, umbilical cord is the preferred source of stem cells over embryonic stem cells and the patient’s own stem cells, which are derived from bone marrow or fat cells. This is due to the fact that umbilical cord is a highly concentrated source for such cells. Finally, umbilical stem cells contain no steroids. The anti-inflammatory agents in these injections are natural and include cytokines.
Relief is Possible
Thousands of sufferers have found that umbilical stem cell therapy for degenerative and rheumatoid arthritis not only provides the relief that they seek, but that it also allows them to begin to improve their condition due to the regenerative powers of such therapy. Stem cells offers a viable and preferred treatment over less effective therapies, such as cortisone injections, which offer limited and temporary relief.
Stem Cell and Platelet Rich Plasma Therapy to help you achieve pain relief from arthritis, tendonitis and ligament injury.
Call today for your stem cell therapy consultation!
The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances.
No statements or treatments on this site have been evaluated or approved by the FDA. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.